Patent · US Expired

Type B botulism toxin inhibitors

US7205435B2 · kind B2 · utility

1Cited by

18References

25Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Bernard Roques · Paris, FR
Christine Anne · Le Plessis-Robinson, FR
Serge Turcaud · Sartrouville, FR
Marie-Claude Fournie-Zaluski · Paris, FR

Key dates

Filing date	Apr 10, 2002
Grant date	Apr 17, 2007
Priority date	—
Expiry date	Jul 10, 2022

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel compounds of general formula (I), are provided with inhibitory properties for the type B botulism toxin activity, along with methods for preparation thereof and corresponding pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.